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MalariaNative and recombinant VDAC preparations differ in their acetylation, phosphorylation and nitrosation state;
additionally, proteineous modulators are missing in the latter. They thus vary in channel characteristics, as can
be taken from comparative black lipid bilayer experiments. Furthermore, the multi-compartment expression
makes expect even differing native VDAC-1 molecules.
Recent structural work on mammalian VDAC-1 has only used recombinant material, refolded from Escherichia
coli inclusion bodies.While this approach established the basic three-dimensional structure of VDAC-1, a ß-barrel
set up by nineteen ß-pleated sheets, dissent is on positioning and movements of its free N-terminal helical pep-
tide stretch preceding ß-pleated sheet-1. A synopsis of data concerning posttranslational modiﬁcations, cyto-
topology and physiology of native VDAC-1, from my point of view, suggests that the ﬁnalisation of its three-
dimensional structure will need native channel preparations to be studied.
Concerning relevance, recent evidence on the regulation of cell membrane-integrated VDAC-1 by posttransla-
tional modiﬁcations and proteineous modulators, taken together with experimental demonstrations that
VDAC-1 is involved in cell volume regulation, it thusmay be part of the extrinsic apoptotic pathway canhopefully
help to understand some relevant medical syndromes, e.g. cystic ﬁbrosis, Alzheimer's disease, autism and
malaria.
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The intention of this minireview is to highlight two recent lines of
VDAC research, that from my point of view are in a mutual relation.
On the one hand, I recall and another time discuss studies that havedemonstrated the inclusion of extra-mitochondrial VDAC-1 into the
plasmalemma. This ﬁnding, for the moment, was hotly refused mostly
because VDAC then had never been seen in a fully closed state. Recent
data on VDAC-1 regulation by posttranslational modiﬁcations and
proteineous modulation, however, not only point to plasmalemmal
VDAC-1 but they help understand its integration into the cell mem-
brane. The recent progress may furthermore help to accept the relevant
role of plasmalemmal VDAC-1 in cell volume regulation and the
1411F.P. Thinnes / Biochimica et Biophysica Acta 1848 (2015) 1410–1416extrinsic apoptotic pathway, and thus put it on the schedule whenever
type-1 VDAC is studied.
On the other hand, according to a recent comparison of recombinant
human type-1 VDACwith nativemitochondria-derived bovine VDAC by
artiﬁcial planar lipid bilayer experiments, the channels are close but dif-
fering. The differences seen, most likely, rest on differences in the post-
translational modiﬁcation of the channel preparations used. A fully
closed VDAC state could not be detected in either case. Together, a sum-
mary of the data available, from my point of view, suggests the follow-
ing: for the ﬁnalisation of the three-dimensional VDAC-1 structure,
native channel preparations will be indispensible.
Tewari and colleges [1] recently reported on effects of Curcumin on
mammalian type-1 VDAC in artiﬁcial lipid bilayer experiments. Accord-
ingly, the agonist connects building blocks of the free N-terminal part of
VDAC-1 with those of the channel wall. This results in a switch from the
canonically open = anion-selective to closed = cation-selective channel
states of type-1 VDAC, and in its ﬁxation to the latter. The study refers an-
other time to an interaction of VDAC-1 and the agonist. Taken together,
the polyphenol blocks the channel and thus appears to be critical for
either apoptotic pathway. Curcumin is established as a pharmakon in Chi-
nese medicine [2–4].
Aside its putative pharmacological relevance, the paper touches an-
other exciting aspect of recent VDAC research. In its Fig. 2, left panel, the
report presents a direct graphical comparison of recombinant human
VDAC-1 obtained by Escherichia coli overexpression and of native bo-
vine VDAC prepared from mitochondria, as elaborated by black mem-
brane measurements. This plot convincingly evidences both forms as
rather close but differing in their channel characteristics. The data are
in linewithmanifold endeavours to electro-physiologically characterise
VDAC from different levels of eukaryotic evolution [5–7] and to eluci-
date the three-dimensional structure and channel characteristics of
vertebrate VDAC by NMR spectroscopy, X-Ray crystallography and sim-
ulation approaches [8–16]. The latter still await ﬁnalisation.
To promote the clarity of the review presented: artiﬁcial lipid bilayer
studies of native [5–7] or recombinant [8–16] VDAC preparations,
respectively, are used to operationally deﬁne several states of channel
regulation depending on the transmembrane voltage (TV) applied.Fig. 1. Localisation of type-1 porin in rat renal cortex by indirect immunocytochemistry perfor
perfusion-ﬁxed cryostat section of rat renal cortex. By indirect immune-peroxidase labelling,
stained. (G Glomerulus, PT proximal tubule, V renal vessel). (b) Electron micrograph of a thin
hanced gold particles are presentmainly in the endocytotic vesicles underneath the microvillar
dria are not labelled due to their inaccessibility to antibodies in the pre-embedding immune-gCanonically, one open=anion-selective state at 10mVTV and a variety
of partially closed = cation-selective states appearing above 30 mV TV
are emphasised. Since 1989, increasing topochemical evidence of the
extra-mitochondrial expression of VDAC-1, in particular its inclusion
into the plasmalemma of vertebrate cells together with the demonstra-
tion of its involvement in cell volume regulation and thus apoptosis
[17–23], argue in favour of a fully closed VDAC-1 state, where ions can-
not pass the channel. For details, see below. Correspondingly, three dif-
fering VDAC states are discussed in recent structural work on type-1
and also type-2 vertebrate VDAC using varying biophysical or in silico
approaches [8–16]; particularly 11].
These are the following: (1) open = anion-selective = N-terminal
stretch of AAs 1–25 inside the barrel; (2) partially closed = cation-se-
lective = N-terminal stretch of AAs 1–25 inside the barrel but in differ-
ing position; and (3) fully closed = collapsed = impermeable for
ions=N-terminal stretch outside the ß-barrel [11], the latter accessible
for antibodies. This is a postulate derived from the proof of cell
membrane-standing VDAC-1 [17–23] (Fig. 1).
2. Phosphorylation, nitrosation and proteineous modulation of
VDAC-1 help understand conductance switches and its involvement
in the extrinsic apoptotic pathway
A series of recent papers on the phosphorylation of plasmalemma-
standing human type-1 VDAC opens up a better understanding of the
channel's switching between different conductance states and further-
more supports its involvement in the process of extrinsic apoptosis
[24–27].
First, the exciting study recently presented by Fernandez-Echevarria
et al. [24] adds some highly relevant new data concerning human type-
1 VDAC. It shows that the channel is abundantly found in neuronal cell
membrane lipid rafts, where the channel is associated in a complex
with signalling proteins that trigger neuro-protective responses. There is
indication that loss of lipid raft integrity may ultimately promote VDAC-
1 activation, and some data had already demonstrated that VDAC-1 at
the neuronalmembranemight be involved in themechanisms of amyloid
beta (Aß)-induced neurotoxicity, through unknown mechanisms. Themed with a monoclonal anti-human type-1 porin antibody [19]. (a) Light micrograph of a
the endocytotic vesicles underneath the brush-border membranes (arrows) are heavily
section of rat renal cortex labelled by “pre-embedding immune-gold staining.” Silver-en-
plasmamembranes of proximal tubule cells. (M,Mitochondrion). Noteworthy, mitochon-
old staining technique. The ﬁgure is taken from Reference [23].
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to the extracellular space where it forms senile plaques. Amyloid Aß ap-
pears bodywide in the circulation system, too. Excitingly, the study dem-
onstrates that VDAC-1 associates with APP and Aß in lipid rafts of
neurons. Furthermore, Aß exposure is shown to enhance the de-
phosphorylation of VDAC-1, in other words, to facilitate channel opening,
and this in correlation with cell death. Both effects were reverted in the
presence of tyrosine phosphatase inhibitors. Noteworthy, VDAC-1 de-
phosphorylation is corroborated in lipid rafts of AD brains. Together,
these results demonstrate that Aß is involved in changes of the phosphor-
ylation state of VDAC-1 in neuronal lipid rafts, a putative mechanism in
the pathogenesis of Alzheimer's Disease.
Second, very recently, Tewari SG et al. [25] presented an analysis of
posttranslationally modiﬁed gating kinetics of VDAC puriﬁed from rat
mitochondria. Accordingly, single channel currents of wild-type,
nitrosated and phosphorylated VDACwere analysed using a generalised
continuous-time Markov chain Monte Carlo method. The method
described three distinct conducting states, open, half-open and closed,
of VDAC activity. Lipid bilayer experiments were also performed to
record single VDAC activity under un-phosphorylated and phosphory-
lated conditions and were analysed using the developed stochastic
search method. Signiﬁcant alterations in VDAC gating kinetics
and conductance were observed as a result of posttranslational modiﬁ-
cations. The effect of PTMs on VDAC kinetics was captured in the
parameters associated with the identiﬁed Markov model. Stationary
distributions of the Markov model suggested that nitrosation of VDAC
not only decreased its conductance but also signiﬁcantly locked VDAC
in a closed state. Compared with that, stationary distributions of the
model associated with un-phosphorylated and phosphorylated VDAC
indicated a reversal in channel conformation from relatively closed
state to an open state. Model analyses of the nitrosated data suggested
that faster reaction of nitric oxidewith Cys-127 thiol groupmight be re-
sponsible for the biphasic effect of nitric oxide on basal VDAC
conductance.
Third, another recent study by Li et al. [26] impressivelywidened the
knowledge concerning the reaction partners of human plasminogen
kringle 5 (K5) and VDAC-1. Here, the K5 molecule induced endothelial
cell (EC) apoptosis and thus showed a potent anti-angiogenesis effect.
While VDAC-1 had already been identiﬁed as a receptor of K5, the chan-
nel has now been shown to increase the protein level of VDAC-1, too,
thus initiating the mitochondrial apoptosis pathway of ECs. The study
has also shown that K5 inhibits the ubiquitin-dependent degradation
of VDAC-1 by promoting phosphorylation of VDAC-1. Hence, phosphor-
ylated VDAC-1 was attenuated by the AKT agonist GSK3ß inhibitor or
corresponding siRNA, suggesting that K5 increases VDAC-1 phosphory-
lation via the AKT-GSK3 pathway. In addition, K5 promoted cell surface
translocation of VDAC-1, resulting in binding between K5 and VDAC-1
on the plasma membrane. Hexokinase I blocked the impact of K5 on
the AKT-GSK3 pathway by competitively inhibiting the interaction of
K5 and cell surface VDAC-1. Moreover, K5-induced EC apoptosis was
suppressed by VDAC-1 antibody. Together, these data show that K5-
induced apoptosis of ECs is mediated by the positive feedback loop of
VDAC1-AKT-GSK3ß-VDAC-1, thus another time putting the channel in
touch with extrinsic apoptosis [20]. For a recent review on VDAC phos-
phorylation concerning cell fate, see [27].
3. Differences concerning native and recombinant VDAC make
native VDAC-1 preparations indispensible for the ﬁnalisation of its
three-dimensional structure.
Aside their relevance concerning the pathogenesis of Alzheimer's
disease, these studies [24–27] point to another important aspect of cur-
rent VDAC research that needs discussion. While demonstrating that
native cell membrane-integrated VDAC-1 of human neuronal cells and
tissues are highly phosphorylated and may furthermore be nitrosated,
recent structural work on the channel uses recombinant VDAC, refoldedfrom E. coli inclusion bodies containing mammalian VDAC-1 or ﬁsh
VDAC-2, respectively [8–16]. Here, a physiologic translational process-
ing of the molecules cannot been expected. No doubt, the approach
has meanwhile established the basic three-dimensional structure of
vertebrate VDAC. Accordingly, the barrels are built up by nineteen
loop-connected ß-pleated sheets, sheet-1, in addition carrying a free
and mostly helical N-terminal stretch of about twenty amino acids
that moves inside the barrel, and this in dependence with the channel's
status of regulation. An adequate demonstration of the fully closed state
of VDAC-1 has not yet been achieved going this way. However,
immune-topochemical data concerning vertebral plasmalemma-
integrated VDAC-1 here argue in favour of a pore-outside positioning
of its free N-terminal peptide stretch. For a discussion of alternative
VDAC models, e.g., postulating that VDAC is open when its free N-
terminal part is found outside the pore see [28,29].
While there is broad consent on the arrangement of the nineteen ß-
sheets of VDAC-1, the scale of movement and ﬁnal positioning of the N-
terminal peptide stretch and its correlation with channel function still
await deﬁnition. However, the papers under discussion here point to
multiple phosphorylation and nitrosation processes as critical steps in
the regulation of native VDAC-1 incorporated into the cell membrane
and thus insinuates to recall biochemical data on this issue (see
below). Those data, frommy point of view, suggest that these days bio-
chemical data exceed the results of structural and simulation work on
recombinant VDAC refolded from E. coli inclusion bodies. Simulation
studies concerning VDAC-1 phosphorylation and its nitrosation may
fail clarity, too.
However, upcoming laser-based approaches will hopefully work
with small amounts of native VDAC-1 in solutions. Endeavours are on
their way to establish X-ray free electron lasers (XFEL) centres trying
to promote techniques that allow determine the structure of biological-
ly relevantmolecules and their interaction in complexes, too, and this in
crystals and in solution. They furthermore search for methods to cap-
ture intermediate states that might be lost in crystals. These efforts
promise beneﬁts also for channel proteins. For example, while 2D crys-
tals ofmembrane proteins usually show lower resolution, they need less
protein and furthermore allow that distinct conformations of the pro-
tein, e.g., open and closed state, of an ion channel may be detected.
Small size nano-crystals of native VDAC-1 may help to leave the dead
end VDAC-1 structure research is currently locked in refs. [30,31];
http://www.embl-hamburg.de/XFEL/annex.html].
Taken together, to care for native vertebrate VDAC preparations
seems to be the order of the day. Suitable preparation methods are at
hand [17,32]. First, starting from highly enriched human B-lymphocyte
cell membranes solubilised in NP40, my laboratory prepared milligram
amounts of channel-active Porin 31HL = VDAC-1 [17] several times;
thematerial after precipitationwas used for the elaboration of the com-
plete primary structure of the molecule. To note, other VDAC isotypes
were not seen in our sequence work. Endeavours to get crystals from
those preparations failed in the ﬁrst step of detergent change (Dr. K.
Zeth, thenworking in the laboratory ofWolframWelte). Second, starting
from enrichedmammalianmitochondria, De Pinto et al. [32] presented a
single-step VDAC puriﬁcation scheme resulting in channel-active prepa-
rations. This approach was later used to elaborate the complete primary
structure of human mitochondria-derived VDAC-1, the most abundant
in OMM, thus proving its molecular identity with plasmalemmal
VDAC-1 [33].
4. Varying phosphorylation and nitrosation states of native
VDAC-1 appear to result in multiple populations of channel
molecules—putatively correlated to differing cell compartments
Theses: the multi-topologic = multi-compartment expression of
mammalian VDAC-1—in whole cell analyses—makes expect the
appearance of several phosphorylation and nitrosation states, resulting
in differing VDAC-1 molecule populations inside cells in parallel.
Fig. 2. Two-dimensional electrophoretic demonstration of sequence grade Porin 31HL =
VDAC-1 obtained by three steps of classic ion-exchange chromatography from highly
enriched B-lymphocyte membranes solubilised in NP40 at pH 5.0. The spots labelled by
Coomassie brilliant blue refer to several isoelectric points of native plasmalemmal type-
1 VDAC, putatively representing several VDAC-1 populations that differ in their phosphor-
ylation state. Data are taken from ref. [18].
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dimensional electrophoreses (see Figs. 4 and 6 of [24]; Fig. 2 of this
review). Unfortunately, there is not much information on transmem-
brane potentials aside from plasmalemma and inner mitochondrial
membrane. However, its phosphorylation and nitrosation can be as-
sumed as basic in VDAC-1 regulation, an aspect worth to keep in mind.
In 1989, ﬁrst data on an extra-mitochondrial expression entered the
VDAC ﬁeld by demonstrating that Porin 31HL=VDAC-1 is expressed in
the plasmalemma of mammalian cells [17,33–38]—data another time
supported by the studies under discussion here. This made VDAC-1 reg-
ulation a key problem, and also opened hunting for its expression and
function(s) in different cell compartment. In trials to explain cell mem-
brane integration of the VDAC-1 channel, interactions with protein-like
and low molecular weight VDAC-1 modulators have been postulated
from the beginning on ref. [34].
Concerning mouse, it has been furthermore proposed that, per usage
of two alternative ﬁrst exons of the murine VDAC-1 gene, two channel
forms differing within their N- termini should be expressed. One of
them, plasmalemmal VDAC-1, carries a hydrophobic leader peptide
and is primarily targeted through the Golgi apparatus to the cell
membrane. In contrast, the second form lacking the N-terminal leader,
mitochondrial VDAC-1, is trans-located more efﬁciently into the
outer mitochondrial membrane [39]. To notice, sequence analyses by
bioinformatics did not identiﬁed a pl-VDAC-1 splice site in the human
gene [40].
Characterisation of nativeVDAC solubilised frommitochondria is usu-
ally gained from black membranes experiments that always map just
open or partially closed channel states, respectively, depending on the
transmembrane voltage applied; concerning human VDAC-1 that nicely
represents eukaryotic porin, see [6]. While recent work on the three-
dimensional structure of recombinant vertebrate VDAC also reports al-
most exclusively on those two channel states [8–16], data fromdifferent
laboratories point to a third regulation state of native VDAC-1 called:
fully closed = collapsed = impermeable for ions = N-terminal stretch
at least partially outside the ß-barrel and accessible for antibodies.
First, the plethora of topologic studies from different laboratories
worldwide using antisera as well as monoclonal antibody preparations
raised against complete native VDAC-1 or selected peptide stretches of
the molecule, respectively, have demonstrated the incorporation of
the channel in the outermembranes ofmitochondria, in the plasmalem-
ma and also in the endoplasmic reticulum membranes [5,6,17,20,21].Second, VDAC-1 in the plasmalemma of HeLa cell, human neuronal
cells and also mouse epithelial cells has been shown to be involved of
the regulatory volume decrease (RVD) after hypotonic stimuli
[40–43]. From here, cell membrane-integrated VDAC-1 is part of the
cell volume regulatory system and thus apoptosis. However, native
VDAC-1 in cell membranes needs to be fully closed in resting cells. To
note, in situ cell volume regulation must be seen in the context of cell's
turnover inducing permanent changes in cell isotonicity. Channels en-
gaged in RVD can thus be expected as ﬂickering, and in accordance
with the studies discussed here [24–27], quick changes in phosphoryla-
tion and nitrosation states of plasmalemma-integrated VDAC-1 can be
assumed to be part of the biochemical basis in the process. However,
while former data just pointed to plasmalemmal VDAC-1 as forming
the channel part of volume regulated anion channels (VRAC, ORDIC,
VSOR, Iclswell) [17,20,21,38–45], now a biochemical understanding
emerges.
Third, monoclonal antibodies reacting with epitopes inside the N-
terminally acetylated peptide stretch AAs 1–11 of human VDAC-1
proved the accessibility of this channel part in a channel-active prepara-
tion of VDAC-1 after solubilisation at pH 5 in NP40 [6].
In a ﬁrst set of experiments, three monoclonal antibodies presented
by Babel et al. [19] were applied after channel reconstitution. No effect
on the channel characteristics or voltage dependence of incorporated
human type-1 VDACwas observed. The channels, inserted at zero trans-
membrane potential, and afterwards ﬁgured as what traditionally is
called the open = anion-selective state. Here, the N-terminal channel
stretch is assumed to be buried inside the channel and thus inaccessible
for the antibodies. Notably, further channel incorporationwas abolished
when antibodies were added at the cis-side of the black membranes,
while trans-application was without effect.
The latter observation ﬁts to the results of a second set of experi-
ments: here Porin 31HL was pre-incubated with the monoclonal anti-
bodies and afterwards added to the aqueous phase of the black lipid
membrane equipment. Now, the reconstitution rate was heavily re-
duced, while channels entering the membrane showed normal eukary-
otic porin behaviour.
The experiments did not allow for a decision whether channels in
contact with the monoclonal antibodies were inserted in fully closed
state or did not enter themembrane at all; however, they can be read
as indicating that VDAC-1 molecules solubilised in NP40 at pH 5 are
in the fully closed = collapsed states, and their N-terminus thus ac-
cessible for antibodies. To note, a recent study applying rat liver
mitochondria-derived VDAC in black membrane experiments dem-
onstrated that acidiﬁcation of the setting reversibly increases VDAC's
voltage-dependent gating and thus promotes channel closure. Fur-
thermore, both anion selectivity and single channel conductance in-
creased with acidiﬁcation [46]. However, a fully closed VDAC state
could not be documented in the experiments. Nevertheless, the re-
sults are in line with the accessibility of the N-terminal free part of
VDAC-1 for corresponding antibodies in solution at pH 5.0.
To get an idea of what may happen whenever VDAC-1 opens up
while entering black membranes, two lines of evidence exist: On the
one hand, it has been shown that native VDAC solubilised in detergents
includes cholesterol in a ratio of ﬁve molecules of cholesterol/polypep-
tide chain [47]. In line, native Porin 31HL solubilised from highly
enriched cell membrane preparations of human B-lymphocytes in the
detergent NP40 at pH 5.0 totally lost channel activity by pre-
incubationwith cyclodextrin. This indicates that stripping off cholester-
ol might mediate the channels entering in black membranes (Thinnes,
unpublished). To notice, vertebrate mammalian VDAC-1 in positions
20 to 24 of its free N-terminal peptide stretch and other positions, too,
carries several GxxxG motifs, good candidates for cholesterol binding
[20,21]. However, solubilised native cell membrane derived and fully
closed VDAC-1/cholesterol complexes appear to open up as open =
anion-selective VDAC-1 phenotypes when entering artiﬁcial lipid
bilayers.
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human VDAC-1 reconstituted in detergent micelles has been pre-
sented. Accordingly, VDAC-1 β-barrel on its hydrophobic outside
carries detergent molecules in belt-like fashion [8]. Here, in the pres-
ence of cholesterol but absence of phosphorylation, recombinant
VDAC-1 forms voltage-gated channels in phospholipid bilayers sim-
ilar to the native protein. Anyway, while Fernandez-Echevarria et al.
[24] have shown that in intact cells the regulation of native VDAC-1
in the plasmalemma depends on the phosphorylation status of the
channel, black membrane experiments with native and recombinant
VDAC-1 point to a high relevance of cholesterol in native VDAC-1/
cholesterol complexes. Additional studies may help to better under-
stand this enigma [45].
5. On the orientation of type-1 VDAC in the plasmalemma and the
outer mitochondrial membrane
There is still a debate on this issue, frommypoint of view, detrimen-
tally focussed on OMM. However, it has been shown by several groups
using different approaches that free acetylated N-terminal peptide
stretches of native VDAC-1 (Ac-1-24) can be labelled by differing anti-
body preparations on the surface of vertebrate cells [5,6,17,20,21,23,
24,26,35–39].
To note, concerning topochemical work on VDAC-1: The inaugu-
ral study on the extra-mitochondrial expression of Porin 31HL =
type-1 VDAC presented in 1989 used a series of rabbit antisera raised
against sequence grade native Porin 31HL or synthetic peptides of it,
respectively; the latter included AAs 1–19 two of them acetylated N-
terminally [17,18]. The monoclonal anti-Porin 31HL antibodies, re-
ported in 1991 [19] and used in topographical studies concerning
OMM and other cell compartments in several laboratories world-
wide [20,21] had been elaborated in a collaboration with
Behringwerke Marburg, Germany; they have been meanwhile
taken from the market. To deﬁne the epitopes seen, we had shown
them to react with the N-terminal tryptic peptide of native type-1
VDAC: Ac-AVPPTYGDLGK comprising eleven AAs; in corresponding
experiments, the N-terminal acetylation had also been shown to be
constitutive for the epitope [22].
By corresponding immune-topographic and biochemical studies
on the transmembrane topology of VDAC at the OMM of bovine mi-
tochondrial porin, De Pinto's laboratory demonstrated in 1991 that
the N-terminal region of the channel, here too, is not embedded in
the lipid bilayer of the OMM but is exposed to the cytosolic side. Fur-
thermore, no difference in the reactivity of the antisera used was ob-
served between intact and broken mitochondria. The group
furthermore summarised its 2007 study on the conformation and
function of the VDAC-1N-terminus by stating that the free peptide
plays a role in the proper function of the protein during apoptotic
events. Finally, the data on the orientation of VDAC-1 in the OMM
were recently another time conﬁrmed [47–49].
In line, a recent study from Varda Shoshan-Barmatz's laboratory,
using site-directed mutagenesis and cysteine residue substitution to-
gether with thiol-speciﬁc cross-linking, revealed that the N-terminal
VDAC-1 region exists in a dynamic equilibrium, located within the
pore or exposed outside the β-barrel, respectively. The free VDAC-1
stretch furthermore proved to be relevant for channel dimerisation
and the docking of hexokinase, Bcl2 and BclXL molecules. Noteworthy,
replacing glycine residues in a GxxxGmotif in positions 20–24 of thena-
tive VDAC-1 molecule referred to the motif as a prerequisite for the
translocation process under discussion. [50].
Contrary to this work, in a corresponding study on the transmem-
brane topology of Neurospora crassa VDAC, presented by Mannella's
laboratory in 1995 [51,52], the reactivity of the antiserum against a
synthetic peptide of its N-terminal end (AAs 1–20) increased with
the lysis of the outer membrane of suspended mitochondria. The au-
thors discussing possible explanations for the discrepancy to DePinto's data referred to differences of the antigens applied for anti-
body production, and to the positioning of the putative epitopes
seen by the antisera used in the two laboratories. As demonstrated
by Fig. 3, the antibodies used quite likely recognised epitopes at op-
posite ends of the N-terminal peptide stretches of human VDAC-1 or
fungal VDAC, respectively.
There is a signiﬁcant difference between vertebrate and plant VDAC,
includingNeurospora crassa and yeast.While vertebrate VDAC1 carries a
GxxxG motif in positions 21 to 25, here marking the end of the free N-
terminal peptide stretch [8–16], this motif is missing in plants [53]. It
is tempting to speculate that plant VDACs have shorter free N-
terminal stretches, necessitating OMM lysis in the study discussed [51,
52]. There is another interesting aspect of the GxxxG motif in position
20 to 24 of native mammalian VDAC-1: aside its putative relevance as
peptide dimerisation/aggregation/membrane perturbation motif it has
been shown to ﬁgure as an ATP binding site [54,55]. To my knowledge,
there are no data on the three-dimensional structure of plant VDAC, but
might be rather useful.6. Conclusion and outlook
Recent studies in focus here, frommy point of view, mark great mo-
ments of VDAC research. The minireview thus tries to accentuate some
aspects of these papers including their medical relevance, points to con-
troversies now vanishing and ﬁnally establishes the claim for native
VDAC-1 preparations to ﬁnalise its three-dimensional structure.
1. The studies of Fernandez-Echevarria et al. [24], Tewari et al. [25] and
Li et al. [26] give strong support to cell membrane-expression, more
precisely plasmalemma lipid raft integration of mammalian VDAC-1.
The data onVDAC-1 posphorylation of cells in culture, this in correla-
tion to channel opening and closing, help understand differing regu-
lation states even in different compartments, and they also argue in
favour of an involvement in cell volume regulation and thus apopto-
sis; recent ﬁndings concerning VDAC nitrosation point in the same
direction. The study of Li et al. [26], furthermore, puts type-1 VDAC
another time in touch with the extrinsic apoptotic pathway. Taken
together, the results recently presented appear to be in line with
much evidence indicating that plasmalemmal VDAC-1 forms the
channel part of a volume regulated anion channel complex (VRAC,
ORDIC, VSOR, Iclswell) and thus apoptosis.
There are increasing data pointing to the medical relevance of cell
membrane-standing VDAC-1 by its involvement in the pathogenesis
of several syndromes via apoptosis, e.g. cancer, cystic ﬁbrosis,
Alzheimer's Disease, autism and malaria [56–60].
2. The ongoing dispute on the accessibility of the N-terminus of VDAC
at cell surfaces or outer mitochondrial membranes by antisera or
monoclonal antibodies, respectively, from my point of view may
proﬁt from an evident difference between animal and plant VDAC.
While animal VDAC-1 at the proximal end of its free N-terminal pep-
tide stretch carries a GxxxGmotif, this motif is missing in plants [53].
From here it maywell pay to elaborate ﬁrst three-dimensional struc-
ture date on plant VDAC, themore as new ideas to understand VDAC
cell membrane incorporation may arise.
3. Endeavours to characterise mammalian VDAC-1 by artiﬁcial lipid
bilayers experiments, obtained either from detergent solubilised plas-
malemma, outermitochondrialmembrane or fromrecombinant chan-
nel preparations refolded from E. coli inclusion bodies, respectively,
just capture the canonical VDAC channel phenotypes open=anion se-
lective and closed=cation selective. The fully closedVDAC-1 state, i.e.,
closed for anions and cations, cannot be studied by this approach. The
same holds true for more recent NMR- or crystallisation-based ap-
proaches. However, upcoming laser techniques may work on native
VDAC-1 in solutions. Thus, improvements to gain solubilised native
VDAC preparation may pay to keep on the schedule.
Fig. 3. (A) Alignment of several animal or vegetal VDAC channels according to Swiss Prot. The alignment, on the one hand, points to a signiﬁcant difference concerning the free N-terminal
part VDAC of animals and plants. While animal VDAC channels carry a GxxxGmotif that ismissing in plants. On the other hand, itmay help to dispel contradictions discussed in the VDAC
community [47–52]. * Initiator methionine replaced by an acetylation. *AVPPTYADLGK: epitope seen bymonoclonal anti-Porin 31HL= VDAC-1 antibodies [19]; Neurospora crassaN-ter-
minal peptide used for antibody building MAVPAFSDIAKSANDLLNKD: epitope seen in the study of Stanley et al. 1995 [51]. (B) Highly schematic two-dimensional projections of human
type-1VDAC trying to summarise data frommyown lab [17] and the laboratories of VitoDe Pinto [47-49], Roland Benz [6], Varda Shoshan-Barmatz [50], CarmenMannella [51,52], and Jeff
Abramson [11]. The fully closed state and the open state of native VDAC-1 are compared.
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